SCHEMBL13660815

SCHEMBL13660815

CCN(CCN1CCCN(C)CC1)C(=O)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.44
SIGMAR1 Q99720 5/20 0.44
TMEM97 Q5BJF2 3/20 0.44
HTR1A P08908 1/20 0.44
CHRM5 P08912 1/20 0.44
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
DRD1 P21728 1/20 0.44
DRD4 P21917 1/20 0.44
DRD5 P21918 1/20 0.44
ADRA1D P25100 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
TSPO P30536 1/20 0.44
ADRA1A P35348 1/20 0.44
HRH1 P35367 1/20 0.44
DRD3 P35462 1/20 0.44
HTR2B P41595 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13661596 0.91 SIGMAR1 (0.46) SIGMAR1HRH3
SCHEMBL13661448 0.85 SIGMAR1 (0.46) HTR7SIGMAR1TMEM97HTR1ACHRM5
SCHEMBL13661589 0.84 CCR6 (0.51) HTR7SIGMAR1TMEM97HTR1ACHRM5
SCHEMBL13661141 0.84 NPC1 (0.49) SIGMAR1HRH3
SCHEMBL13661574 0.83 CCR6 (0.50) HTR7SIGMAR1TMEM97HTR1ACHRM5
SCHEMBL13660817 0.83 KDM4E (0.52) SIGMAR1HRH3
SCHEMBL13660801 0.83 OPRM1 (0.49) SIGMAR1CCR5
SCHEMBL13660806 0.81 OPRM1 (0.47) SIGMAR1TMEM97HRH3CCR5
SCHEMBL13661326 0.79 CCR6 (0.48) HTR7SIGMAR1TMEM97HTR1ACHRM5
Hydrochloric Acid SCHEMBL23354635 0.79 SIGMAR1 (0.47) SIGMAR1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009131246-A1 SORDARIN DERIVATIVES FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS ASTELLAS PHARMA INC. (JP) 2009-10-29 WO disclosed